The role of infection in the instability of atherosclerotic plaques has bee
n questioned because of discrepancies in the results of clinical trials tha
t tested antibiotics in acute coronary syndromes. The results of the Random
ized Trial of Roxithromycin in Non-Q-Wave Coronary Syndromes (ROXIS) are su
mmarized and contrasted with two other pilot studies of antibiotic therapy
of coronary artery disease. Relevant characteristics of patients enrolled a
nd rationales for these trials are discussed and serologic results are pres
ented.